{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T03:29:21Z","timestamp":1767410961481,"version":"3.48.0"},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,1,1]]},"DOI":"10.2169\/internalmedicine.5578-25","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T18:07:37Z","timestamp":1750270057000},"page":"167-172","source":"Crossref","is-referenced-by-count":1,"title":["Methotrexate-associated Angioimmunoblastic T-cell Lymphoma Presenting with Acute Kidney Injury"],"prefix":"10.2169","volume":"65","author":[{"given":"Satoshi","family":"Ichikawa","sequence":"first","affiliation":[{"name":"Division of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Japan"},{"name":"Department of Hematology, Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikaru","family":"Kumagai","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Onodera","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Okitsu","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shori","family":"Abe","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiyoshi","family":"Fujishima","sequence":"additional","affiliation":[{"name":"Division of Diagnostic Pathology, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Ichinohasama","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, Tohoku University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Kameoka","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Ishii","sequence":"additional","affiliation":[{"name":"Division of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. WHO Classification of Tumours Editorial Board. Haematolymphoid Tumours: WHO Classification of Tumours. 5th ed. IARC, 2024."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Satou A, Tabata T, Miyoshi H, et al. Methotrexate-associated lymphoproliferative disorders of T-cell phenotype: clinicopathological analysis of 28 cases. Mod Pathol 32: 1135-1146, 2019.","DOI":"10.1038\/s41379-019-0264-2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Zhang F, Li W, Cui Q, Chen Y, Liu Y. Case report: immune microenvironment and mutation features in a patient with Epstein-Barr virus positive large B-cell lymphoma secondary to angioimmunoblastic T-cell lymphoma. Front Genet 13: 940513, 2022.","DOI":"10.3389\/fgene.2022.940513"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hashimoto A, Asai S, Tanaka Y, Shinzato I. Epstein-Barr virus-positive adrenal diffuse large B-cell lymphoma after treatment for angioimmunoblastic T-cell lymphoma. Eur J Case Rep Intern Med 8: 002533, 2021.","DOI":"10.12890\/2021_002533"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Poon F, Ieremia E, Collins G, Matin RN. Epstein-Barr virus-induced cutaneous diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma. Am J Dermatopathol 41: 927-930, 2019.","DOI":"10.1097\/DAD.0000000000001371"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chen H, Xue YN, Xin CM, Xiong JS, Ni X, Sun JF. Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma with Hodgkin\/Reed-Sternberg-like cells in a patient with angioimmunoblastic T-cell lymphoma. Acta Derm Venereol 98: 981-982, 2018.","DOI":"10.2340\/00015555-2996"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lee T, Park BG, You E, et al. Bone marrow involvement of Epstein-Barr virus-positive large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma. Ann Lab Med 38: 172-175, 2018.","DOI":"10.3343\/alm.2018.38.2.172"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Advani RH, Skrypets T, Civallero M, et al. Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project. Blood 138: 213-220, 2021.","DOI":"10.1182\/blood.2020010387"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Murakami H, Makita M, Ishikawa T, et al. Angioimmunoblastic T-cell lymphoma presenting as a methotrexate-associated lymphoproliferative disorder with extreme peripheral blood plasmacytosis. Intern Med 61: 2655-2660, 2022.","DOI":"10.2169\/internalmedicine.8422-21"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ishibuchi H, Motegi S, Yamanaka M, Amano H, Ishikawa O. Methotrexate-associated lymphoproliferative disorder: sequential development of angioimmunoblastic T-cell lymphoma-like lymphoproliferation in the lymph nodes and diffuse large B-cell lymphoma in the skin in the same patient. Eur J Dermatol 25: 361-362, 2015.","DOI":"10.1684\/ejd.2015.2582"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hatanaka K, Nakamura N, Kojima M, et al. Methotrexate-associated lymphoproliferative disorders mimicking angioimmunoblastic T-cell lymphoma. Pathol Res Pract 206: 9-13, 2010.","DOI":"10.1016\/j.prp.2009.03.005"},{"key":"12","unstructured":"12. Hoshida Y, Xu JX, Fujita S, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol 34: 322-331, 2007."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Staffolani E, Nicolais R, Manca di Villahermosa S, Galli D, Postorino M, Di Daniele N. Cytokine removal under hemodiafiltration with endogenous reinfusion in acute kidney injury secondary to angioimmunoblastic T-cell lymphoma: a case report. Blood Purif 34: 349-353, 2012.","DOI":"10.1159\/000346288"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Li XY, He HY, Yue SL, Pai P. Delayed diagnosis of Angioimmunoblast T-cell lymphoma presenting with type II Cryoglobulinemia and acute kidney injury: a case report and narrative review of the literature. BMC Nephrol 21: 463, 2020.","DOI":"10.1186\/s12882-020-02125-9"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. De Samblanx  H, Verhoef G, Zach\u00e9e P, Vandenberghe P. A male with angioimmunoblastic T-cell lymphoma and proliferative glomerulonephritis. Ann Hematol 83: 455-459, 2004.","DOI":"10.1007\/s00277-003-0828-5"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Zhao M, Guan Y, Lin J, Qiu Y, Zhao S, Duan M. Acute kidney injury in critical care: complications of hemophagocytic lymphohistiocytosis. Front Immunol 15: 1396124, 2024.","DOI":"10.3389\/fimmu.2024.1396124"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nahum E, Ben-Ari J, Stain J, Schonfeld T. Hemophagocytic lymphohistiocytic syndrome: unrecognized cause of multiple organ failure. Pediatr Crit Care Med 1: 51-54, 2000.","DOI":"10.1097\/00130478-200007000-00010"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/1\/65_5578-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T03:26:41Z","timestamp":1767410801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/1\/65_5578-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5578-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"5578-25"}}